Justin Low

Justin Low is a seasoned scientist with 25 years of extensive experience in the research and development of large molecule therapeutics. They served as a Research Associate at Fred Hutch from 1997 to 2001, where they contributed significantly to monoclonal antibody generation. Justin further advanced their skills at Schering-Plough Biopharma as a Scientist, developing humanized monoclonal antibodies for therapeutic use from 2001 to 2006. Currently, they are a Scientist 4 at Genentech, specializing in biophysical characterization and the production of polyclonal antibodies, while also leading and training personnel in the department. Justin holds a BSc in Biochemistry from the University of Washington.